Business Categories Reports Podcasts Events Awards
Contact My Account About

Why Does Aesthetics Overlook the First 72 Hours?

Published November 17, 2026
Published November 17, 2026
Teoxane

Injectables remain a staple of aesthetic medicine, but patients are broadening their definition of a good result. They’re looking beyond what a single procedure can correct to how their skin looks and feels over time. While injectables remain a cornerstone of treatment, patient expectations are moving beyond the correction of individual concerns toward a broader goal: achieving healthier, optimized skin. As skin quality becomes a defining measure of aesthetic success, practitioners are rethinking treatment strategies and patient journeys accordingly.

According to Research and Markets, the global medical aesthetics market is expected to grow from $20.2 billion in 2026 to $39 billion by 2032, driven by growing demand for minimally invasive procedures, natural-looking outcomes, and shorter recovery times.

“Patients no longer think in single procedures. They think about how their skin looks and feels over time,” said Can Ongen, COO of Swiss laboratory company Teoxane. “The future of aesthetics won’t be won by launching more products but by making them work together. When practitioners have a coherent path from treatment to recovery to maintenance, patients get better results and have more reason to trust the clinic guiding them.”

This integrated approach is reflected in Teoxane’s latest innovation, RHA Topical Skin Booster, a topical treatment developed exclusively for professional use and specifically designed to support skin barrier recovery during the immediate post-procedure period.

For more than two decades, Teoxane has been an expert in hyaluronic acids in aesthetics. The sterile formulation utilizes Teoxane's patented Resilient Hyaluronic Acid (RHA) technology, originally developed for the company's injectable fillers. The company is now drawing on its experience with injectables to develop in-office topical products designed to support recovery and improve skin quality around aesthetic procedures.

The Crucial 72-hour Window

As procedures such as microneedling, energy-based treatments, and chemical peels continue to gain popularity, attention has traditionally focused on the treatment itself. Yet what happens immediately after the procedure may be just as important.

Carine Blondin, Global Aesthetic Skincare Director at Teoxane, said that the conversation often ends when the patient leaves the treatment room, and it shouldn’t. “In the first 72 hours, the skin is rebuilding its barrier, recovering hydration, and remodeling tissue, and it is unusually receptive. That is the moment we designed RHA Topical Skin Booster for.”

“Patients no longer think in single procedures. They think about how their skin looks and feels over time.”
By Can Ongen, COO, Teoxane

Designed for skin's most critical recovery window, leveraging the skin's greatest opportunity for renewal.

The solution combines low molecular weight hyaluronic acid to maintain hydration and skin quality, collagen, and a revitalizing complex of amino acids, antioxidants, vitamins, and minerals, carefully selected to support skin barrier hydration and overall skin quality. Formulated with 12.5% of our proprietary RHA skincare ingredient, the booster offers its highest concentration ever in a topical solution.

“This is the most RHA we have ever put into a topical formulation, and it was a deliberate choice,” Blondin said. “Skin that has just been treated has specific needs, so we brought the hyaluronic acid science and technology behind our injectables to that moment, to support hydration, barrier function, and resilience.”

By leveraging the same hyaluronic acid expertise that has made Teoxane a leader in HA injectable aesthetics, RHA Topical Skin Booster extends the benefits of RHA technology into the post-procedure environment, creating continuity between treatment and recovery.

Clinical evaluations demonstrated a 17.6% reduction in transepidermal water loss within one hour, helping support barrier recovery; a 60% increase in collagen production after five days in association with microneedling; enhanced hyaluronic acid production within the epidermis; and improvements in hydration, smoothness, firmness, and overall skin quality perception.

Dermatologist Dr. Ted Lain said he found it particularly compelling that RHA Topical Skin Booster does more than just hydrate the skin. “The data suggests it supports key biological mechanisms involved in recovery, including hyaluronic acid production, collagen synthesis, and barrier repair,” Lain said. “By leveraging the skin’s natural regenerative response during the post-procedure window, it has the potential to meaningfully enhance skin quality outcomes."

With RHA Topical Skin Booster, Teoxane gives practitioners a way to start post-procedure skincare while the patient is still in the treatment room. It’s a small change in when skincare begins that makes recovery part of the appointment itself.